IL2 and neoplasm: These studies employed 2-phase TIL expansion protocols comprised of an initial pre-rapid expansion phase wherein tumor tissues are cultured with IL-2 to support T-cell division and survival, and a subsequent process of T-cell selection based on tumor reactivity followed by 14-days of rapid expansion (REP).